Knowledge Center
Patent / Jan 11, 2024
Dry powder inhaler pharmaceutical composition of coated crystalline dry powder for inhalation
Source:
WO 2024009079 A1
The present invention describes a dry powder inhaler pharmaceutical composition comprising one or more active pharmaceutical ingredients (API) coated with one or more force control agents (FCA) with optimized aerodynamic performance by micronizing crystalline API particles to the respirable range and coating the particles with a force control agent. The present invention also id pharmaceutical composition, and its use in medicine.
Ìý
Also in the Knowledge Center
/ Jan 01, 2012
Design, preparation and characterization of novel molecularly imprinted polymers for removal of potentially genotoxic 1,3-diisopropylurea from API solutions
Read more
Scientific Article
/ Jan 01, 2012
Design of experiments as a tool for LC-MS/MS method development for the trace analysis of the potentially genotoxic 4-dimethylaminopyridine impurity in glucocorticoids
Read more
Scientific Article
Scientific Article